182 related articles for article (PubMed ID: 26002511)
1. CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48.
Holm NB; Nielsen LM; Linnet K
AAPS J; 2015 Sep; 17(5):1237-45. PubMed ID: 26002511
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
Nielsen LM; Holm NB; Olsen L; Linnet K
Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
[TBL] [Abstract][Full Text] [Related]
3. Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.
Holm NB; Pedersen AJ; Dalsgaard PW; Linnet K
Drug Test Anal; 2015 Mar; 7(3):199-206. PubMed ID: 24802286
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
[TBL] [Abstract][Full Text] [Related]
5. Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity.
Pinson A; Yarbrough AL; Bush JM; Cabanlong CV; Shoeib A; Jackson BK; Fukuda S; Gogoi J; Fantegrossi WE; McCain K; Prather PL; Fujiwara R; Radominska-Pandya A
Pharmacol Biochem Behav; 2020 Aug; 195():172949. PubMed ID: 32413436
[TBL] [Abstract][Full Text] [Related]
6. Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135).
Jones S; Yarbrough AL; Fantegrossi WE; Prather PL; Bush JM; Radominska-Pandya A; Fujiwara R
Pharmacol Res Perspect; 2020 Feb; 8(1):e00561. PubMed ID: 32003945
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
[TBL] [Abstract][Full Text] [Related]
8. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
Moody DE; Liu F; Fang WB
J Anal Toxicol; 2015 Jun; 39(5):374-86. PubMed ID: 25868557
[TBL] [Abstract][Full Text] [Related]
9. In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s.
Kim JH; Kim HS; Kong TY; Lee JY; Kim JY; In MK; Lee HS
J Pharm Biomed Anal; 2016 Feb; 119():50-8. PubMed ID: 26641707
[TBL] [Abstract][Full Text] [Related]
10. Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic.
Ji HY; Lee HW; Kim HH; Kim DS; Yoo M; Kim WB; Lee HS
Xenobiotica; 2004; 34(11-12):973-82. PubMed ID: 15801542
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes.
Hao X; Yuan J; Xu Y; Wang Z; Hou J; Hu T
Xenobiotica; 2018 Dec; 48(12):1185-1191. PubMed ID: 28385095
[TBL] [Abstract][Full Text] [Related]
12. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Br J Pharmacol; 2003 Apr; 138(8):1465-74. PubMed ID: 12721102
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
Erratico C; Negreira N; Norouzizadeh H; Covaci A; Neels H; Maudens K; van Nuijs AL
Drug Test Anal; 2015 Oct; 7(10):866-76. PubMed ID: 25865117
[TBL] [Abstract][Full Text] [Related]
14. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism.
Yang TJ; Krausz KW; Sai Y; Gonzalez FJ; Gelboin HV
Drug Metab Dispos; 1999 Jan; 27(1):102-9. PubMed ID: 9884317
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
Minoletti C; Dijols S; Dansette PM; Mansuy D
Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.
Chimalakonda KC; Seely KA; Bratton SM; Brents LK; Moran CL; Endres GW; James LP; Hollenberg PF; Prather PL; Radominska-Pandya A; Moran JH
Drug Metab Dispos; 2012 Nov; 40(11):2174-84. PubMed ID: 22904561
[TBL] [Abstract][Full Text] [Related]
17.
Li M; Liu X; Wang Y; Ju X
Xenobiotica; 2020 Oct; 50(10):1202-1207. PubMed ID: 32338127
[TBL] [Abstract][Full Text] [Related]
18. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
19. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
[TBL] [Abstract][Full Text] [Related]
20.
Ding B; Ji X; Sun X; Zhang T; Mu S
Xenobiotica; 2020 Aug; 50(8):913-918. PubMed ID: 32026737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]